Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.28−0.17 (-0.83%)
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Viatris's revenue for the twelve months ending Jun 30, 2026 was $14.74B, up 4.4% year over year. For fiscal 2025 it was $14.30B, down 3.0% from the year before. The highest annual figure on record is $17.89B in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.30B | -3.0% |
| FY2024 | Dec 31, 2024 | $14.74B | -4.5% |
| FY2023 | Dec 31, 2023 | $15.43B | -5.1% |
| FY2022 | Dec 31, 2022 | $16.26B | -9.1% |
| FY2021 | Dec 31, 2021 | $17.89B | +49.7% |
| FY2020 | Dec 31, 2020 | $11.95B | +3.9% |
| FY2019 | Dec 31, 2019 | $11.50B | +0.6% |
| FY2018 | Dec 31, 2018 | $11.43B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.76B | +4.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.52B | +8.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.70B | +5.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.76B | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $3.58B | -5.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.25B | -11.2% |
| Q4 FY2024 | Dec 31, 2024 | $3.53B | -8.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.75B | -4.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.80B | -3.1% |
| Q1 FY2024 | Mar 31, 2024 | $3.66B | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.84B | -1.0% |
| Q3 FY2023 | Sep 30, 2023 | $3.94B | -3.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.92B | -4.8% |
| Q1 FY2023 | Mar 31, 2023 | $3.73B | -11.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.88B | -10.7% |
| Q3 FY2022 | Sep 30, 2022 | $4.08B | -10.1% |
| Q2 FY2022 | Jun 30, 2022 | $4.12B | -10.1% |
| Q1 FY2022 | Mar 31, 2022 | $4.19B | -5.4% |
| Q4 FY2021 | Dec 31, 2021 | $4.34B | +19.8% |
| Q3 FY2021 | Sep 30, 2021 | $4.54B | +52.6% |
| Q2 FY2021 | Jun 30, 2021 | $4.58B | +67.6% |
| Q1 FY2021 | Mar 31, 2021 | $4.43B | +69.1% |
| Q4 FY2020 | Dec 31, 2020 | $3.62B | – |
| Q3 FY2020 | Sep 30, 2020 | $2.97B | – |
| Q2 FY2020 | Jun 30, 2020 | $2.73B | – |
| Q1 FY2020 | Mar 31, 2020 | $2.62B | – |
| Q3 FY2019 | Sep 29, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
See a number that looks wrong?